The automotive world has always been full of unexpected turns — but some car manufacturers took a completely new dire ...

Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) investors of an upcoming deadline involving a securities ...

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Charles ...

ICON plc, No. 25-cv-01807 ("PFRSD"). PFRSD is related to the class action an investor previously filed against ICON: Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.) ("Shing"), which is the first ...

Cruz announces that investors with losses related to ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR ...

notifies investors that a class action lawsuit has been filed against ICON PLC ("ICON" or "the Company") (NASDAQ:ICLR) and certain of its officers. Class Definition This lawsuit seeks to recover ...

Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: ICON is a clinical research organization ("CRO"). The ICON class action lawsuit alleges that ...

SAN DIEGO, April 7, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR ) ordinary shares between July 27, 2023 and January 13, 2025 ...